{"id":1076,"date":"2017-08-01T06:35:43","date_gmt":"2017-08-01T06:35:43","guid":{"rendered":"https:\/\/xavant.com\/?p=1076"},"modified":"2018-10-15T16:38:32","modified_gmt":"2018-10-15T14:38:32","slug":"stimpod-nms460-receives-fda-clearance-usa","status":"publish","type":"post","link":"https:\/\/xavant.com\/de\/stimpod-nms460-receives-fda-clearance-usa\/","title":{"rendered":"Stimpod NMS460 erh\u00e4lt die FDA-Zulassung (USA)"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><div class=\"vc_row wpb_row vc_row-fluid\"><div class=\"wpb_column vc_column_container vc_col-sm-12\"><div class=\"vc_column-inner\"><div class=\"wpb_wrapper\">\n\t<div class=\"wpb_text_column wpb_content_element\" >\n\t\t<div class=\"wpb_wrapper\">\n\t\t\t<p><strong>Pretoria, S\u00fcdafrika<\/strong>\u00a0- Xavant Technology (Pty) Ltd gab heute bekannt, dass die US-amerikanische Food and Drug Administration (FDA) ihr Stimpod NMS460 zugelassen hat. Dieses nicht-invasive Neuromodulationsger\u00e4t, f\u00fcr das ein US-Patent auf eine propriet\u00e4re hybride gepulste Radiofrequenz (PRF)-Wellenform erteilt wurde, konzentriert sich auf die symptomatische Linderung und Behandlung von chronischen hartn\u00e4ckigen Schmerzen sowie auf eine erg\u00e4nzende Behandlung bei der Behandlung von postoperativen Schmerzen, akuten posttraumatischen Schmerzproblemen und eine erg\u00e4nzende Behandlung zur Schmerzkontrolle bei der Rehabilitation.<\/p>\n<p>Der Bedarf an diesem Ger\u00e4t ist sehr gro\u00df. Mehr als 100 Millionen Amerikaner geben an, dass sie ein Problem mit Schmerzen haben.<a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftn1\" name=\"_ftnref1\">[1]<\/a>\u00a0\u00a0Chronische Schmerzen sind durch neuroplastische Ver\u00e4nderungen gekennzeichnet, die zu einer Sensibilisierung des Nervensystems f\u00fchren. Diese Ver\u00e4nderungen f\u00fchren zu anatomischen und physiologischen Ver\u00e4nderungen, die sich auf die neurologische Funktion auswirken, was eine Langzeitpotenzierung und Ver\u00e4nderungen der Genexpression zur Folge hat, die es dem Schmerz erm\u00f6glichen, mit oder ohne weiteren peripheren Input fortzufahren, und zu einer niedrigeren Schmerzschwelle f\u00fchren; diese Funktionsst\u00f6rung ist dann auch f\u00fcr die mit der Krankheit verbundenen Epiph\u00e4nomene verantwortlich, einschlie\u00dflich emotionaler, ged\u00e4chtnism\u00e4\u00dfiger und motorischer Ver\u00e4nderungen, die dann zur Krankheit des chronischen Schmerzes werden.<a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftn2\" name=\"_ftnref2\">[2]<\/a><\/p>\n<p>Die Behandlung chronischer Schmerzen in den Vereinigten Staaten kostet sch\u00e4tzungsweise $600 Milliarden j\u00e4hrlich.<a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftn3\" name=\"_ftnref3\">[3]<\/a>\u00a0Die derzeitige Standardtherapie f\u00fcr chronische Schmerzen umfasst einen Medikamentencocktail aus Kortikosteroiden, Opiaten, Injektionen und anderen Medikamenten in Kombination mit Behandlungen wie Physiotherapie und Beratung. Die Behandlungen k\u00f6nnen mit verschiedenen kurz- und langfristigen Nebenwirkungen einhergehen.<\/p>\n<p>Der Stimpod NMS460 wird jedoch als nicht-invasive, nicht-medikament\u00f6se L\u00f6sung ohne Nebenwirkungen und mit schnellem Wirkungseintritt zu einem Bruchteil der Kosten vergleichbarer Behandlungen einen gro\u00dfen Einfluss auf die Branche haben. Das Ger\u00e4t wendet seine patentierte PRF-Wellenform transkutan auf den betroffenen Bereich an. Diese Wellenform erzeugt elektromagnetische Effekte, die mit invasiven gepulsten Radiofrequenzbehandlungen vergleichbar sind, und mehrere Fallstudien haben eine sofortige und dramatische Linderung von chronischen, hartn\u00e4ckigen Schmerzen gezeigt. Der Stimpod NMS460 verf\u00fcgt au\u00dferdem \u00fcber eine Nervenlokalisierungstechnologie mit einer Nervenkartierungssonde, die es dem Arzt erm\u00f6glicht, Nerven zu lokalisieren und den Behandlungsfortschritt bei gesch\u00e4digten Nerven zu beurteilen. Bell Medical wurde als Hauptvertriebsh\u00e4ndler f\u00fcr die USA und Kanada ausgew\u00e4hlt.<\/p>\n<p>\"Wir sind begeistert von der Nachricht, dass unser revolution\u00e4res Ger\u00e4t nun auch in den USA eingesetzt werden kann\", sagte Corlius Birkill, CEO von Xavant Technology (Pty) Ltd. \"Diese bahnbrechende Technologie hat das Potenzial, Dutzenden, wenn nicht Hunderten von Millionen Menschen allein in den USA zu helfen, da sie eine wertvolle Behandlungshilfe f\u00fcr Neurologen, Chiropraktiker, Akupunkteure, Physiotherapeuten, Physiologen und medizinische Schmerztherapeuten darstellt.\"<\/p>\n<p><a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftnref1\" name=\"_ftn1\">[1]<\/a>\u00a0Gaskin, Darrell J., und Patrick Richard. \"Die wirtschaftlichen Kosten des Schmerzes in den Vereinigten Staaten\".\u00a0<em>The Journal of Pain: Offizielle Zeitschrift der Amerikanischen Schmerzgesellschaft<\/em>\u00a0(2012): 715-24. Web. 21. Juni 2017.<\/p>\n<p><a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftnref2\" name=\"_ftn2\">[2]<\/a>\u00a0Amerikanische Akademie f\u00fcr Schmerzmedizin.\u00a0<em>Neuropathischer Schmerz wird als Krankheit anerkannt<\/em>. N.p.: American Medical Association, 27 Sept. 2016. PDF.\u00a0<a href=\"https:\/\/assets.ama-assn.org\/sub\/meeting\/documents\/i16-resolution-912.pdf\" target=\"_blank\" rel=\"noopener\">https:\/\/assets.ama-assn.org\/sub\/meeting\/documents\/i16-resolution-912.pdf<\/a><\/p>\n<p><a href=\"https:\/\/www.stimpodnms460.com\/news\/#_ftnref3\" name=\"_ftn3\">[3]<\/a>\u00a0Gaskin, Darrell J., und Patrick Richard. \"Die wirtschaftlichen Kosten des Schmerzes in den Vereinigten Staaten\".\u00a0<em>The Journal of Pain: Offizielle Zeitschrift der Amerikanischen Schmerzgesellschaft<\/em>\u00a0(2012): 715-24. Web. 21. Juni 2017.<\/p>\n\n\t\t<\/div>\n\t<\/div>\n<\/div><\/div><\/div><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Pretoria, S\u00fcdafrika - Xavant Technology (Pty) Ltd gab heute bekannt, dass die US-amerikanische Food and Drug Administration (FDA) ihr Stimpod NMS460 zugelassen hat. Dieses nicht-invasive Neuromodulationsger\u00e4t, f\u00fcr das ein US-Patent auf eine propriet\u00e4re hybride gepulste Radiofrequenz (PRF)-Wellenform erteilt wurde, konzentriert sich auf die symptomatische Linderung und das Management chronischer hartn\u00e4ckiger Schmerzen sowie...<\/p>","protected":false},"author":2,"featured_media":1077,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[],"class_list":["post-1076","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-7","description-off"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Stimpod NMS460 Receives FDA Clearance (USA) | Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/xavant.com\/de\/stimpod-nms460-receives-fda-clearance-usa\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stimpod NMS460 Receives FDA Clearance (USA) | Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping\" \/>\n<meta property=\"og:url\" content=\"https:\/\/xavant.com\/de\/stimpod-nms460-receives-fda-clearance-usa\/\" \/>\n<meta property=\"og:site_name\" content=\"Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/XavantTechnology\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-08-01T06:35:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-10-15T14:38:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"400\" \/>\n\t<meta property=\"og:image:height\" content=\"314\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Xavant Technology\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@XavantTech\" \/>\n<meta name=\"twitter:site\" content=\"@XavantTech\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Xavant Technology\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"3\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\"},\"author\":{\"name\":\"Xavant Technology\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#\\\/schema\\\/person\\\/c8384e46abaf5f32420beb9c3d237ac9\"},\"headline\":\"Stimpod NMS460 Receives FDA Clearance (USA)\",\"datePublished\":\"2017-08-01T06:35:43+00:00\",\"dateModified\":\"2018-10-15T14:38:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\"},\"wordCount\":512,\"publisher\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/fda-cleared_news.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\",\"url\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\",\"name\":\"Stimpod NMS460 Receives FDA Clearance (USA) | Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/fda-cleared_news.jpg\",\"datePublished\":\"2017-08-01T06:35:43+00:00\",\"dateModified\":\"2018-10-15T14:38:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#primaryimage\",\"url\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/fda-cleared_news.jpg\",\"contentUrl\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/08\\\/fda-cleared_news.jpg\",\"width\":400,\"height\":314},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/xavant.com\\\/stimpod-nms460-receives-fda-clearance-usa\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/xavant.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stimpod NMS460 Receives FDA Clearance (USA)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#website\",\"url\":\"https:\\\/\\\/xavant.com\\\/\",\"name\":\"Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping\",\"description\":\"Developers of Quantitative TOF Monitors (NMT Monitors), Nerve Mapping and Locating devices.\",\"publisher\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/xavant.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#organization\",\"name\":\"Xavant Technology\",\"url\":\"https:\\\/\\\/xavant.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/10\\\/Xavant-Logo-Original-Colours.png\",\"contentUrl\":\"https:\\\/\\\/xavant.com\\\/wp-content\\\/uploads\\\/2018\\\/10\\\/Xavant-Logo-Original-Colours.png\",\"width\":1636,\"height\":306,\"caption\":\"Xavant Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/xavant.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/XavantTechnology\\\/\",\"https:\\\/\\\/x.com\\\/XavantTech\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/xavant-technology\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/xavant.com\\\/#\\\/schema\\\/person\\\/c8384e46abaf5f32420beb9c3d237ac9\",\"name\":\"Xavant Technology\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g\",\"caption\":\"Xavant Technology\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stimpod NMS460 erh\u00e4lt FDA-Zulassung (USA) | Xavant Technology | TOF-Monitore, NMT-\u00dcberwachung, Nerve Mapping","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/xavant.com\/de\/stimpod-nms460-receives-fda-clearance-usa\/","og_locale":"de_DE","og_type":"article","og_title":"Stimpod NMS460 Receives FDA Clearance (USA) | Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping","og_url":"https:\/\/xavant.com\/de\/stimpod-nms460-receives-fda-clearance-usa\/","og_site_name":"Xavant Technology | TOF Monitors, NMT Monitoring, Nerve Mapping","article_publisher":"https:\/\/www.facebook.com\/XavantTechnology\/","article_published_time":"2017-08-01T06:35:43+00:00","article_modified_time":"2018-10-15T14:38:32+00:00","og_image":[{"width":400,"height":314,"url":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","type":"image\/jpeg"}],"author":"Xavant Technology","twitter_card":"summary_large_image","twitter_creator":"@XavantTech","twitter_site":"@XavantTech","twitter_misc":{"Verfasst von":"Xavant Technology","Gesch\u00e4tzte Lesezeit":"3\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#article","isPartOf":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/"},"author":{"name":"Xavant Technology","@id":"https:\/\/xavant.com\/#\/schema\/person\/c8384e46abaf5f32420beb9c3d237ac9"},"headline":"Stimpod NMS460 Receives FDA Clearance (USA)","datePublished":"2017-08-01T06:35:43+00:00","dateModified":"2018-10-15T14:38:32+00:00","mainEntityOfPage":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/"},"wordCount":512,"publisher":{"@id":"https:\/\/xavant.com\/#organization"},"image":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","articleSection":["News"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/","url":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/","name":"Stimpod NMS460 erh\u00e4lt FDA-Zulassung (USA) | Xavant Technology | TOF-Monitore, NMT-\u00dcberwachung, Nerve Mapping","isPartOf":{"@id":"https:\/\/xavant.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#primaryimage"},"image":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#primaryimage"},"thumbnailUrl":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","datePublished":"2017-08-01T06:35:43+00:00","dateModified":"2018-10-15T14:38:32+00:00","breadcrumb":{"@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#primaryimage","url":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","contentUrl":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/08\/fda-cleared_news.jpg","width":400,"height":314},{"@type":"BreadcrumbList","@id":"https:\/\/xavant.com\/stimpod-nms460-receives-fda-clearance-usa\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/xavant.com\/"},{"@type":"ListItem","position":2,"name":"Stimpod NMS460 Receives FDA Clearance (USA)"}]},{"@type":"WebSite","@id":"https:\/\/xavant.com\/#website","url":"https:\/\/xavant.com\/","name":"Xavant Technology | TOF-Monitore, NMT-\u00dcberwachung, Nervenkartierung","description":"Entwickler von quantitativen TOF-Monitoren (NMT-Monitoren), Nervenkartierungs- und Lokalisierungsger\u00e4ten.","publisher":{"@id":"https:\/\/xavant.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/xavant.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/xavant.com\/#organization","name":"Xavant Technologie","url":"https:\/\/xavant.com\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/xavant.com\/#\/schema\/logo\/image\/","url":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/10\/Xavant-Logo-Original-Colours.png","contentUrl":"https:\/\/xavant.com\/wp-content\/uploads\/2018\/10\/Xavant-Logo-Original-Colours.png","width":1636,"height":306,"caption":"Xavant Technology"},"image":{"@id":"https:\/\/xavant.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/XavantTechnology\/","https:\/\/x.com\/XavantTech","https:\/\/www.linkedin.com\/company\/xavant-technology\/"]},{"@type":"Person","@id":"https:\/\/xavant.com\/#\/schema\/person\/c8384e46abaf5f32420beb9c3d237ac9","name":"Xavant Technologie","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/cc3d4616cfe17ac20387a5ebea88c52e96b171c5c1871830086f4e836a604974?s=96&d=mm&r=g","caption":"Xavant Technology"}}]}},"_links":{"self":[{"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/posts\/1076","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/comments?post=1076"}],"version-history":[{"count":0,"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/posts\/1076\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/media\/1077"}],"wp:attachment":[{"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/media?parent=1076"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/categories?post=1076"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xavant.com\/de\/wp-json\/wp\/v2\/tags?post=1076"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}